Block listing Interim Review

RNS Number : 8493G

Circassia Group Plc

01 April 2022

 

Circassia Group plc

Block Listing Interim Review

Oxford, UK - 1 April 2022:  Circassia Group plc (LSE: CIR),  a medical device company focused on point of care asthma diagnosis and management , makes the following notification pursuant to Schedule Six of the AIM Rules for Companies regarding its existing block listing arrangements:

Name of the company:		Circassia Group plc
Name of relevant scheme:		1)  Circassia EMI Share Option Scheme 2)  Circassia 2007 Unapproved Share Scheme 3)  Circassia 2014 Performance Share Plan Scheme 4)  Circassia 2015 Performance Share Plan Scheme 5)  Circassia 2016 Performance Share Plan Scheme 6)  Circassia 2017 Performance Share Plan Scheme 7)  Circassia 2020 Save As You Earn Scheme (UK) 8)  Circassia 2020 Performance Share Plan Scheme 9)  Circassia 2020 Deferred Share Bonus Plan
Period of return:	From:	1 October 2021	To:	31 March 2022
Balance of unallotted securities under scheme(s) from previous return:		1)  700,750 2)  203,000 3)  76,676 4)  172,722 5)  580,926 6)  50,672 7)  1,126,893 8)  0 9)  0 Total  2,911,639
Plus:   The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):		1) - 5) inclusive: Nil 6)  250,000 7)  0 8)  184,091 9)  823,467
Less:   Number of securities issued/allotted under scheme(s) during period:		1) - 5) inclusive: Nil 6)  (12,050) 7)  (61,335) 8)  (184,091) 9)  (823,467) Total  (1,080,943)
Equals:   Balance under scheme(s) not yet issued/allotted at end of period:		1)  700,750 2)  203,000 3)  76,676 4)  172,722 5)  580,926 6)  288,622 7)  1,065,558 8)  0 9)  0 Total  3,088,254
Number and class of securities originally listed and the date of admission:		1)  2,600,000 - 20 March 2014 2)  516,000 - 1 June 2017 3)  500,000 - 1 June 2017 4)  400,000 - 21 May 2018 5)  930,000 - 1 July 2019 6)  980,000 - 22 May 2020 6)  250,000 - 11 October 2021 7)  1,141,658 - 1 April 2021 8)  184,091 - 2 December 2021 9)  823,467 - 28 March 2022

Name of contact:	Sarah Duncan
Telephone number of contact:	01865 405 560

For further information, please contact:

Singer Capital Markets (Nominated Adviser and Broker) Aubrey Powell / Jen Boorer

Tel: [phone]

 

END

 

 

BLRDZGFFVMFGZZM